Dusp1 in osteolytic diseases-mechanisms and therapeutic potential
Abstract Osteolytic diseases are a significant and escalating global public health issue, driven by the acceleration of population aging and the rising incidence of degenerative, metabolic, and neoplastic diseases. The primary therapeutic strategy for osteolytic diseases is to suppress the bone reso...
Saved in:
| Main Authors: | Boyu Liu, Ming Lei, Baicheng Wan, Yanbing Feng, Yilin Teng, Deshuang Xi, Shou Chen, Gaofeng Zeng, Shaohui Zong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-05142-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Echinococcus granulosus sensu lato promotes osteoclast differentiation through DUSP4-MAPK signaling in osseous echinococcosis
by: Haohao Sun, et al.
Published: (2025-03-01) -
The MAP kinase negative regulator DUSP2 (dual specificity phosphatase 2) is controlled by oncogenic microRNA cluster miR-17-92, miR-106a-363 and miR-106b-25
by: Victoria Tenhaken, et al.
Published: (2025-06-01) -
Study on the effects of spermidine on LPS-induced inflammatory osteolysis in mouse calvaria
by: ZHAO Xinyu, et al.
Published: (2025-06-01) -
Self-powered intracellular nanogenerator attenuates inflammatory osteolysis through mitochondrial MRS2/Mg2+-mediated macrophage repolarization and osteoclastogenesis inhibition
by: Jiyuan Zuo, et al.
Published: (2025-08-01) -
GORHAM-STOUT SYNDROME: DESCRIPTION OF A CASE
by: Elvira Nikolayevna Otteva, et al.
Published: (2010-08-01)